MAPT and Alzheimer disease: In the NABD group, both tau and phosphorylated tau proteins were elevated in 71.4% (tau protein in 35.7% and ptau181 in 71.4%) and in 100% of those with AD (tau protein in 86% and ptau181 in 100%).